Czech National Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.9M | Buy |
62,770
+3,790
| +6% | +$1.69M | 0.22% | 90 |
|
|
2025
Q1 | $28.6M | Buy |
58,980
+3,142
| +6% | +$1.52M | 0.26% | 80 |
|
|
2024
Q4 | $22.5M | Buy |
55,838
+3,260
| +6% | +$1.31M | 0.21% | 90 |
|
|
2024
Q3 | $24.5M | Buy |
52,578
+3,404
| +7% | +$1.58M | 0.25% | 77 |
|
|
2024
Q2 | $23M | Buy |
49,174
+3,832
| +8% | +$1.8M | 0.26% | 77 |
|
|
2024
Q1 | $19M | Buy |
45,342
+203
| +0.4% | +$84.9K | 0.24% | 84 |
|
|
2023
Q4 | $18.4M | Buy |
45,139
+29
| +0.1% | +$11.8K | 0.26% | 80 |
|
|
2023
Q3 | $15.7M | Buy |
45,110
+14,621
| +48% | +$5.08M | 0.25% | 85 |
|
|
2023
Q2 | $10.7M | Buy |
30,489
+194
| +0.6% | +$68.3K | 0.24% | 87 |
|
|
2023
Q1 | $9.55M | Buy |
30,295
+249
| +0.8% | +$78.5K | 0.24% | 94 |
|
|
2022
Q4 | $8.68M | Buy |
30,046
+242
| +0.8% | +$69.9K | 0.23% | 103 |
|
|
2022
Q3 | $8.63M | Buy |
+29,804
| New | +$8.63M | 0.25% | 87 |
|